Astec LifeSciences Limited announced standalone and consolidated unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the standalone company reported net sales of INR 472.871 million compared with INR 382.551 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 59.339 million compared with INR 35.363 million for the same period a year ago. Profit from ordinary activities before tax was INR 25.612 million compared with INR 6.760 million for the same period a year ago. Net profit was INR 22.614 million or INR 1.22 per basic and diluted share compared with INR 3.339 million or INR 0.20 per basic and diluted share for the same period a year ago.

For the nine months, the standalone company reported net sales of INR 1,474.897 million compared with INR 1,083.178 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 184.318 million compared with INR 116.037 million for the same period a year ago. Profit from ordinary activities before tax was INR 91.413 million compared with INR 55.597 million for the same period a year ago. Net profit was INR 73.462 million or INR 3.96 per basic and diluted share compared with INR 37.257 million or INR 1.83 per basic and diluted share for the same period a year ago.

For the quarter, the consolidated company reported net sales of INR 506.994 million compared with INR 405.578 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 59.519 million compared with INR 36.230 million for the same period a year ago. Profit from ordinary activities before tax was INR 24.298 million compared with INR 3.698 million for the same period a year ago. Net profit was INR 21.300 million or INR 1.15 per basic and diluted share compared with INR 0.277 million or INR 0.02 per basic and diluted share for the same period a year ago.

For the nine months, the consolidated company reported net sales of INR 1,603.559 million compared with INR 1,172.697 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 189.147 million compared with INR 121.592 million for the same period a year ago. Profit from ordinary activities before tax was INR 88.559 million compared with INR 51.871 million for the same period a year ago. Net profit was INR 70.608 million or INR 3.90 per basic and diluted share compared with INR 33.205 million or INR 1.96 per basic and diluted share for the same period a year ago.